RESTRICTED AREA
* The information contained on this page is intended for veterinarians or animal health professionals with the ability to prescribe and/or dispense medicines.If you meet these requirements, talk to our sales department.
Ref.: DC 01 300
HY-50
Hyaluronic Acid
If you have already registered, log in to GirovetPro
Description
PHARMACEUTICAL FORM
Injectable solution. Clear, colorless and viscous solution.
SPECIES
Horses.
Injectable solution. Clear, colorless and viscous solution.
SPECIES
Horses.
Indications
For intraarticular and intravenous treatment of lameness caused by joint disorders related to non-infectious synovitis.
Dose / Application / Administration
Route of administration:
Intraarticular or intravenous.
Dosage:
Intravenous use: 3ml intravenously for a total of three treatments at weekly intervals.
For a single intraarticular injection: intraarticular injection of 3ml (51mg) in medium and big joints. The smaller articulations, such as Las articulaciones más pequeñas, tales como las articulaciones intratarsus, tarsus-metatarsus and interphalangeal, can be treated with a 1,5ml (25,5mg) dose.
More than one joint can be treated at a time.
As far as possible, excess synovial liquid should be removed before the injection.
Intraarticular or intravenous.
Dosage:
Intravenous use: 3ml intravenously for a total of three treatments at weekly intervals.
For a single intraarticular injection: intraarticular injection of 3ml (51mg) in medium and big joints. The smaller articulations, such as Las articulaciones más pequeñas, tales como las articulaciones intratarsus, tarsus-metatarsus and interphalangeal, can be treated with a 1,5ml (25,5mg) dose.
More than one joint can be treated at a time.
As far as possible, excess synovial liquid should be removed before the injection.
The safety of this medication in pregnant or lactating females has not been proven. The veterinarian must assess the benefit-risk ratio before its use.
*For more complete information, check the technical data sheet.
Composition
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance:
Sodium hyaluronate: 17mg/ml
Active substance:
Sodium hyaluronate: 17mg/ml
Presentation
3ml syringe
Laboratory
DECHRA
Leave us your comment